Stockhead on MSN11h
AdAlta prioritises ‘East to West’ cellular immunotherapy strategy to drive value creation
AdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.
Researchers develop targeted treatment for aggressive pregnancy cancer
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...
Science Daily2h
Researchers find improved method for treating rare, aggressive, pregnancy-related cancer
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.
Life's Crucial 9 negatively linked to overactive bladder
Life's Crucial 9 (LC9), a recently proposed method for assessing cardiovascular health, has a strong negative correlation ...